- December 5, 2022
- Newsletter
- 617-430-5616
Menu
Brand Name :
Opcon-a, Visine-A, naphcon-A
Synonyms :
Naphazoline hydrochloride and pheniramine maleate
Class :
Antihistamine, decongestant
Dosage Forms & Strengths
Ophthalmic solution
0.025%/0.3%
0.027%/0.3%
Ophthalmic solution
up to 4 times a day
Solution
1-2 drops instilled into the affected eye
Dosage Forms & Strengths
Ophthalmic solution
0.025%/0.3%
0.027%/0.3%
<6 years: Not established:
>6 years: 1-2 drops instilled into the affected eye up to 4 times a day
may increase the hypertension effect of alfa one agonist
may increase the hypertension effect of sympathomimetic drugs
may decrease the therapeutic effects of decongestants
may increase the hypertension effect of sympathomimetic drugs
may increase the vasoconstriction effect of sympathomimetic drugs
may increase the vasoconstriction effect of sympathomimetic drugs
may increase the vasoconstriction effect of sympathomimetic drugs
may increase the vasoconstriction effect of sympathomimetic drugs
may increase the vasoconstriction effect of sympathomimetic drugs
may increase the adverse effect of sympathomimetic drugs
may increase the adverse effect of sympathomimetic drugs
may increase the adverse effect of sympathomimetic drugs
may increase the adverse effect of sympathomimetic drugs
may increase the adverse effect of sympathomimetic drugs
may decrease the constriction effects of alpha-1 agonist
bunazosin (Not available in the United States)
may decrease the constriction effects of alpha-1 agonist
may decrease the constriction effects of alpha-1 agonist
may decrease the constriction effects of alpha-1 agonist
may decrease the constriction effects of alpha-1 agonist
may increase the hypertension effect of sympathomimetic drugs
may increase the adverse effect of sympathomimetic drugs
may diminish the serum concentration of decongestants
may increase the tachycardiac effect of sympathomimetic drugs
may increase the hypertension effect of sympathomimetic drugs
may increase the hypertension effect of alfa one agonist
may increase the hypertension effect of sympathomimetic drugs
may increase the hypertension effect of sympathomimetic drugs
may increase the therapeutic effect of alfa one agonist
Frequency defined:
Ocular erythema
Stinging sensation upon instillation
Mydriasis
Pregnancy consideration: Insufficient data available
Lactation: Excretion of the drug in human breast milk is unknown
Pregnancy category:
Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester.
Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women.
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.
Category D: adequate data available with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.
Category N: There is no data available for the drug under this category
Patient information leaflet
Generic Name: Naphazoline/pheniramine
Pronounced: na-FAZ-oh-leen/ fen-EER-a-meen
Why do we use Naphazoline/pheniramine?
It is intended to temporarily treat allergy-related ocular symptoms like eye redness, puffiness, itching, and watering.